{"id":29687,"date":"2023-06-13T16:23:03","date_gmt":"2023-06-13T15:23:03","guid":{"rendered":"https:\/\/touchrespiratory.com\/?post_type=media_gallery&p=29687"},"modified":"2023-06-21T11:41:42","modified_gmt":"2023-06-21T10:41:42","slug":"the-us-bronchiectasis-and-ntm-research-registry-aims-and-clinical-developments-mark-metersky-ats-2023","status":"publish","type":"media_gallery","link":"https:\/\/touchrespiratory.com\/bronchiectasis\/conference-hub\/the-us-bronchiectasis-and-ntm-research-registry-aims-and-clinical-developments-mark-metersky-ats-2023\/","title":{"rendered":"The US Bronchiectasis and NTM Research Registry – aims and clinical developments: Mark Metersky, ATS 2023"},"content":{"rendered":"

The US Bronchiectasis and NTM Research Registry is a centralized database for the study of adult patients with non-cystic fibrosis bronchiectasis. In this interview Dr. Mark Metersky<\/strong> (UConn Health, Farmington, CT, USA) discusses the current challenges in the diagnosis and management of bronchiectasis and NTM, the aims of the registry and how it could impact clinical developments and patient outcomes in bronchiectasis and NTM.<\/p>\n

The following analyses of the registry were presented at\u00a0ATS 2023, 19-24 May 2023<\/a>:<\/p>\n